Deamination, the opposite of amination, is a type of post-translational modification (PTM) in which an amine group is removed from a protein. Enzymes that catalyze the deamination reaction are called deaminases. Typically in humans, deamination occurs when an excess in protein is consumed, resulting in the removal of an amine group, which is then converted into ammonia and expelled via urination. This deamination process allows the body to convert excess amino acids into usable by-products. Although deamination occurs throughout the human body, it is most common in the liver and to a lesser extent in the kidneys.
Deamination Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Deamination below!
For more information on how to use Laverne, please read the How to Guide.
We have 638 products for the study of Deamination that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.